Extension Sought on Comments Regarding Patent Listing

On June 1, 2020, in Docket FDA-2020-N-1127 and published in the Federal Register, the Agency asked for public comment regarding updating and clarifying the types of patents that could be listed in the Orange Book (here).  The document sought comments on two specific issues of continued interest: should patents be submitted to the FDA and […]

Read More